BNP Paribas Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39.5M Sell
215,436
-30,244
-12% -$5.57M 0.05% 376
2025
Q4
$43.2M Buy
245,680
+48,777
+25% +$7.97M 0.05% 339
2025
Q3
$27.6M Buy
196,903
+33,273
+20% +$4.5M 0.07% 276
2025
Q2
$20.6M Buy
163,630
+11,037
+7% +$1.38M 0.05% 346
2025
Q1
$20.9M Sell
152,593
-25,875
-14% -$3.7M 0.06% 333
2024
Q4
$27.3M Sell
178,468
-220,936
-55% -$37.3M 0.07% 277
2024
Q3
$77.4M Sell
399,404
-33,438
-8% -$7M 0.19% 121
2024
Q2
$100M Sell
432,842
-137,691
-24% -$29.9M 0.26% 87
2024
Q1
$123M Buy
570,533
+122,101
+27% +$28.6M 0.33% 65
2023
Q4
$116M Sell
448,432
-212,114
-32% -$52.1M 0.32% 71
2023
Q3
$170M Buy
660,546
+108,841
+20% +$29.1M 0.52% 33
2023
Q2
$157M Buy
551,705
+142,793
+35% +$42.5M 0.49% 42
2023
Q1
$114M Buy
408,912
+23,502
+6% +$6.5M 0.39% 53
2022
Q4
$107M Buy
385,410
+38,818
+11% +$11M 0.38% 58
2022
Q3
$92.5M Sell
346,592
-1,462
-0.4% -$311K 0.36% 59
2022
Q2
$71M Buy
348,054
+1,037
+0.3% +$212K 0.27% 88
2022
Q1
$73.1M Buy
347,017
+103,355
+42% +$22.5M 0.25% 88
2021
Q4
$58.5M Sell
243,662
-59,318
-20% -$15.3M 0.2% 121
2021
Q3
$85.7M Buy
302,980
+41,710
+16% +$13.7M 0.32% 70
2021
Q2
$90.5M Sell
261,270
-27,970
-10% -$8.47M 0.32% 63
2021
Q1
$80.9M Buy
289,240
+30,519
+12% +$8.23M 0.33% 67
2020
Q4
$63.4M Buy
258,721
+8,414
+3% +$2.17M 0.29% 84
2020
Q3
$71M Buy
250,307
+93,491
+60% +$26.1M 0.4% 55
2020
Q2
$42M Sell
156,816
-12,034
-7% -$3.62M 0.28% 95
2020
Q1
$53.4M Buy
168,850
+4,128
+3% +$1.25M 0.45% 46
2019
Q4
$48.9M Buy
164,722
+22,849
+16% +$6.34M 0.33% 75
2019
Q3
$33M Buy
141,873
+38,227
+37% +$8.9M 0.25% 111
2019
Q2
$24.2M Sell
103,646
-42,081
-29% -$9.72M 0.2% 145
2019
Q1
$34.4M Buy
145,727
+25,275
+21% +$7.96M 0.29% 80
2018
Q4
$35.4M Buy
120,452
+11,830
+11% +$3.78M 0.33% 69
2018
Q3
$38.4M Buy
108,622
+15,576
+17% +$5.36M 0.29% 81
2018
Q2
$27M Sell
93,046
-18,107
-16% -$5.09M 0.23% 114
2018
Q1
$30.4M Buy
111,153
+20,757
+23% +$6.44M 0.26% 105
2017
Q4
$28.8M Buy
90,396
+14,655
+19% +$4.7M 0.25% 95
2017
Q3
$23.7M Sell
75,741
-1,043
-1% -$309K 0.2% 122
2017
Q2
$20.8M Sell
76,784
-687
-0.9% -$182K 0.18% 126
2017
Q1
$21.2M Sell
77,471
-8,453
-10% -$2.39M 0.19% 118
2016
Q4
$24.4M Buy
85,924
+15,009
+21% +$4.45M 0.23% 111
2016
Q3
$22.2M Buy
70,915
+12,557
+22% +$3.72M 0.19% 130
2016
Q2
$14.1M Sell
58,358
-105,843
-64% -$27.9M 0.12% 232
2016
Q1
$42.7M Sell
164,201
-52,018
-24% -$13.7M 0.36% 65
2015
Q4
$66.2M Sell
216,219
-12,846
-6% -$3.69M 0.56% 34
2015
Q3
$66.8M Buy
229,065
+5,345
+2% +$1.77M 0.59% 26
2015
Q2
$90.4M Sell
223,720
-69,247
-24% -$27.8M 0.73% 15
2015
Q1
$124M Buy
292,967
+110,127
+60% +$43.4M 0.94% 4
2014
Q4
$62.1M Sell
182,840
-13,397
-7% -$4.33M 0.5% 39
2014
Q3
$64.9M Sell
196,237
-23,367
-11% -$7.7M 0.53% 35
2014
Q2
$69.2M Sell
219,604
-105,617
-32% -$31.8M 0.54% 36
2014
Q1
$99.5M Buy
325,221
+17,904
+6% +$5.68M 0.75% 18
2013
Q4
$86M Sell
307,317
-70,678
-19% -$18.3M 0.64% 26
2013
Q3
$91M Sell
377,995
-70,354
-16% -$15.7M 0.68% 24
2013
Q2
$96.5M Buy
+448,349
New +$95.8M 0.72% 27

Other funds holding BIIB